These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2883059)
1. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Fuessl HS; Carolan G; Williams G; Bloom SR Digestion; 1987; 36(2):101-7. PubMed ID: 2883059 [TBL] [Abstract][Full Text] [Related]
2. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. Nelson-Piercy C; Hammond PJ; Gwilliam ME; Khandan-Nia N; Myers MJ; Ghatei MA; Bloom SR J Clin Endocrinol Metab; 1994 Feb; 78(2):329-36. PubMed ID: 7906279 [TBL] [Abstract][Full Text] [Related]
3. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I Digestion; 1987; 36(2):108-24. PubMed ID: 2883060 [TBL] [Abstract][Full Text] [Related]
4. Effect of enprostil on gastric emptying, intestinal transit time and post-prandial release of gastro-intestinal peptides. Nicholl CG; Carolan G; Sevelius H; Bloom SR Digestion; 1989; 43(1-2):47-55. PubMed ID: 2509267 [TBL] [Abstract][Full Text] [Related]
5. The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers. van Berge Henegouwen MI; van Gulik TM; Akkermans LM; Jansen JB; Gouma DJ Gut; 1997 Dec; 41(6):758-62. PubMed ID: 9471423 [TBL] [Abstract][Full Text] [Related]
6. Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Møller N; Petrany G; Cassidy D; Sheldon WL; Johnston DG; Laker MF Clin Sci (Lond); 1988 Oct; 75(4):345-50. PubMed ID: 3058374 [TBL] [Abstract][Full Text] [Related]
7. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus. Spinas GA; Bock A; Keller U Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093 [TBL] [Abstract][Full Text] [Related]
8. Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release. Salminen EK; Salminen SJ; Porkka L; Kwasowski P; Marks V; Koivistoinen PE Am J Clin Nutr; 1989 Jun; 49(6):1228-32. PubMed ID: 2658536 [TBL] [Abstract][Full Text] [Related]
9. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Allen JM; Fitzpatrick ML; Yeats JC; Darcy K; Adrian TE; Bloom SR Digestion; 1984; 30(4):255-62. PubMed ID: 6548978 [TBL] [Abstract][Full Text] [Related]
10. Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time. Ladas SD; Latoufis C; Giannopoulou H; Hatziioannou J; Raptis SA Dig Dis Sci; 1989 Jun; 34(6):919-24. PubMed ID: 2656138 [TBL] [Abstract][Full Text] [Related]
11. Effect of somatostatin-14 on gastric emptying and on gastrin and insulin release after ingestion of a mixed solid-liquid meal in man. Jonderko G; Jonderko K; Gołab T Mater Med Pol; 1989; 21(3):174-80. PubMed ID: 2577474 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920 [TBL] [Abstract][Full Text] [Related]
13. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Savage AP; Adrian TE; Carolan G; Chatterjee VK; Bloom SR Gut; 1987 Feb; 28(2):166-70. PubMed ID: 3557189 [TBL] [Abstract][Full Text] [Related]
14. Delayed mouth-caecum transit of a lactulose labelled liquid test meal in patients with steatorrhoea caused by partially treated coeliac disease. Spiller RC; Lee YC; Edge C; Ralphs DN; Stewart JS; Bloom SR; Silk DB Gut; 1987 Oct; 28(10):1275-82. PubMed ID: 3678957 [TBL] [Abstract][Full Text] [Related]
15. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea. Read NW; Miles CA; Fisher D; Holgate AM; Kime ND; Mitchell MA; Reeve AM; Roche TB; Walker M Gastroenterology; 1980 Dec; 79(6):1276-82. PubMed ID: 7439633 [TBL] [Abstract][Full Text] [Related]
16. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Cooper JC; Williams NS; King RF; Barker MC Br J Surg; 1986 Feb; 73(2):128-31. PubMed ID: 2868771 [TBL] [Abstract][Full Text] [Related]
17. Postprandial effects of SMS 201-995 on gut hormones and glucose tolerance. Williams G; Fuessl H; Kraenzlin M; Bloom SR Scand J Gastroenterol Suppl; 1986; 119():73-83. PubMed ID: 2876509 [TBL] [Abstract][Full Text] [Related]
18. [Patients with liver cirrhosis: mouth-cecum transit time and gastric emptying of solid foods]. Chesta J; Lillo R; Defilippi C; Jouanee E; Massone MA; Maulén M; Zavala A Rev Med Chil; 1991 Nov; 119(11):1248-53. PubMed ID: 9723075 [TBL] [Abstract][Full Text] [Related]
19. Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis. Taylor CJ; Hillel PG; Ghosal S; Frier M; Senior S; Tindale WB; Read N Arch Dis Child; 1999 Feb; 80(2):149-52. PubMed ID: 10325730 [TBL] [Abstract][Full Text] [Related]
20. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]